Tiotropium Add-On and Treatable Traits in Asthma-COPD Overlap: A Real-World Pilot Study

References

• To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Publ Health. 2012;12:204. doi:10.1186/1471-2458-12-204
   PubMed Web of Science ®Google Scholar
• Adachi M, Kozawa M, Yoshisue H, et al. Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: a long-term post-marketing study in Japan. Respir Med. 2018;141:56–63. PMID: 30053973. doi:10.1016/j.rmed.2018.06.021
   PubMed Web of Science ®Google Scholar
• Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135:896–902. doi:10.1016/j.jaci.2014.08.042
   PubMed Web of Science ®Google Scholar
• McDonald VM, Clark VL, Cordova-Rivera L, Wark PAB, Baines KJ, Gibson PG. Targeting treatable traits in severe asthma: a randomised controlled trial. Eur Respir J. 2020;55(3):1901509. doi:10.1183/13993003.01509-2019
   PubMed Web of Science ®Google Scholar
• McDonald VM, Osadnik CR, Gibson PG. Treatable traits in acute exacerbations of chronic airway diseases. Chron Respir Dis. 2019;16:1479973119867954. doi:10.1177/1479973119867954
   Web of Science ®Google Scholar
• Jarjour NN, Erzurum SC, Bleecker ER, et al.; NHLBI Severe Asthma Research Program (SARP). Severe asthma: lessons learned from the National heart, lung, and blood institute severe asthma research program. Am J Respir Crit Care Med. 2012;185(4):356–362. doi:10.1164/rccm.201107-1317PP
   PubMed Web of Science ®Google Scholar
• Gaspar Marques J, Lobato M, Leiria Pinto P, Neuparth N, Carreiro Martins P. Asthma and COPD “overlap”: a treatable trait or common several treatable-traits? Eur Ann Allergy Clin Immunol. 2020;52(4):148–159. doi:10.23822/EurAnnACI.1764-1489.138
   PubMed Web of Science ®Google Scholar
• Fu JJ, Gibson PG, Simpson JL, McDonald VM. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration. 2014;87:63–74. doi:10.1159/000352053
   PubMed Web of Science ®Google Scholar
• Ishiura Y, Fujimura M, Shiba Y, Ohkura N, Hara J, Kasahara K. A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-daily fluticasone propionate/salmeterol in Asthma-COPD overlap syndrome. Pulm Pharmacol Ther. 2015;35:28–33. doi:10.1016/j.pupt.2015.10.005
   PubMed Web of Science ®Google Scholar
• Ishiura Y, Fujimura M, Ohkura N, et al. Effect of triple therapy in patients with asthma-COPD overlap. Int J Clin Pharmacol Ther. 2019;57(8):384–392. doi:10.5414/CP203382
   PubMed Web of Science ®Google Scholar
• Ishiura Y, Fujimura M, Ohkura N, et al. Therapy with budesonide/glycopyrrolate/formoterol fumarate improves inspiratory capacity in patients with asthma-chronic obstructive pulmonary disease overlap. Int J Chron Obstruct Pulmon Dis. 2020;15:269–277. doi:10.2147/COPD.S231004
   PubMed Web of Science ®Google Scholar
• Buhl R, FitzGerald JM, Busse WW. Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β 2-agonists for adults with asthma. Respir Med. 2018;143:82–90. doi:10.1016/j.rmed.2018.08.014
   PubMed Web of Science ®Google Scholar
• Doherty DE, Bleecker ER, Moroni-Zentgraf P, Zaremba-Pechmann L, Kerstjens HAM. Tiotropium respimat efficacy and safety in asthma: relationship to age. J Allergy Clin Immunol Pract. 2020;8(8):2653–2660.e4. doi:10.1016/j.jaip.2020.04.013
   PubMed Web of Science ®Google Scholar
• Incorvaia C, Riario-Sforza GG, Pravettoni C, Yacoub MR, Frati F. Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium. Int J Chron Obstruct Pulmon Dis. 2008;3(1):123–126. doi:10.2147/copd.s2386
   PubMedGoogle Scholar
• Marsh SE, Travers J, Weatherall M, et al. Proportional classification of COPD phenotypes. Thorax. 2008;63(9):761–767. doi:10.1136/thx.2007.089193
   PubMed Web of Science ®Google Scholar
• Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8):728–735. doi:10.1136/thx.2008.108027
   PubMed Web of Science ®Google Scholar
• Ishiura Y, Fujimura M, Yamamoto H, Ishiguro T, Ohkura N, Myou S. COX-2 inhibition attenuates cough reflex sensitivity to inhaled capsaicin in patients with asthma. J Investig Allergol Clin Immunol. 2009;19:370–374.
   PubMedGoogle Scholar
• Ishiura Y, Fujimura M, Yamamoto H, Ohkura N, Myou S. Role of COX-2 in cough reflex sensitivity to inhaled capsaicin in patients with sinobronchial syndrome. Cough. 2010;6(1):7. doi:10.1186/1745-9974-6-7
   PubMedGoogle Scholar
• Ishiura Y, Fujimura M, Shiba Y, et al. A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-daily fluticasone propionate/salmeterol in elderly asthmatics. Drug Res. 2018;68(1):38–44. doi:10.1055/s-0043-118536
   Web of Science ®Google Scholar
• Oostveen E, MacLeod D, Lorino H, et al.; Force on Respiratory Impedance Measurements. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22:1026–1041. doi:10.1183/09031936.03.00089403
   PubMed Web of Science ®Google Scholar
• Mori K, Shirai T, Mikamo M, et al. Colored 3-dimensional analyses of respiratory resistance and reactance in COPD and asthma. COPD. 2011;8(6):456–463. doi:10.3109/15412555.2011.626818
   PubMedGoogle Scholar
• Alving K, Janson C, Nordvall L. Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res. 2006;7(1):67. doi:10.1186/1465-9921-7-67
   PubMed Web of Science ®Google Scholar
• Werner CU, Linde K, Schäffner J, Storr C, Schneider A. Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients. NPJ Prim Care Respir Med. 2017;27(1):64. doi:10.1038/s41533-017-0064-4
   PubMed Web of Science ®Google Scholar
• Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA. Usefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med. 2012;185:1218–1224. doi:10.1164/rccm.201110-1843OC
   PubMed Web of Science ®Google Scholar
• Matza LS, Park J, Coyne KS, Skinner EP, Malley KG, Wolever RQ. Derivation and validation of the ASK-12 adherence barrier survey. Ann Pharmacother. 2009;43(10):1621–1630. doi:10.1345/aph.1M174
   PubMed Web of Science ®Google Scholar
• Chari VM, McIvor RA. Tiotropium for the treatment of asthma: patient selection and perspectives. Can Respir J. 2018;2018:3464960. doi:10.1155/2018/3464960
   PubMed Web of Science ®Google Scholar
• Park HK, Song WJ. Sex and treatable traits in severe asthma. Allergy Asthma Immunol Res. 2021;13(2):167–170. doi:10.4168/aair.2021.13.2.167
   PubMed Web of Science ®Google Scholar
• Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410–419. doi:10.1183/13993003.01359-2015
   PubMed Web of Science ®Google Scholar
• Iwanaga T, Tohda Y, Nakamura S, Suga Y. The respimat ® soft mist inhaler: implications of drug delivery characteristics for patients. Clin Drug Investig. 2019;39(11):1021–1030. doi:10.1007/s40261-019-00835-z
   PubMed Web of Science ®Google Scholar
• Casarosa P, Bouyssou T, Germeyer S, Schnapp A, Gantner F, Pieper M. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs. J Pharmacol Exp Ther. 2009;330(2):660–668. PMID: 19478135. doi:10.1124/jpet.109.152470
   PubMed Web of Science ®Google Scholar
• Cazzola M, Ora J, Rogliani P, Matera MG. Role of muscarinic antagonists in asthma therapy Expert. Rev Respir Med. 2017;11(3):239–253. doi:10.1080/17476348.2017.1289844
   Web of Science ®Google Scholar
• Hoshino M, Ohtawa J, Akitsu K. Effects of the addition of tiotropium on airway dimensions in symptomatic asthma. Allergy Asthma Proc. 2016;37(6):147–153. doi:10.2500/aap.2016.37.3991
   PubMed Web of Science ®Google Scholar
• Wise RA, Anzueto A, Cotton D, et al.; TIOSPIR Investigators. Tiotropium respimat inhaler and the risk of death in COPD. N Engl J Med. 2013;369(16):1491–1501. PMID: 23992515. doi:10.1056/NEJMoa1303342
   PubMed Web of Science ®Google Scholar
• Corren J, Mansfield LE, Pertseva T, Blahzko V, Kaiser K. Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma. Respir Med. 2013;107(2):180–195. doi:10.1016/j.rmed.2012.10.025
   PubMed Web of Science ®Google Scholar
• Papi A, Mansur AH, Pertseva T, et al. Long-term fluticasone propionate/formoterol fumarate combination therapy is associated with a low incidence of severe asthma exacerbations. J Aerosol Med Pulm Drug Deliv. 2016;29(4):346–361. doi:10.1089/jamp.2015.1255
   PubMed Web of Science ®Google Scholar
• Benfante A, Braido F, Scichilone N. The anti-inflammatory properties of tiotropium. Lancet Respir Med. 2018;6(8):e37. doi:10.1016/S2213-2600(18)30190-5
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish guideline for COPD (GesEPOC). Arch Bronconeumol. 2014;50(Suppl 1):1–16. doi:10.1016/S0300-2896(14)70070-5
   PubMed Web of Science ®Google Scholar
• The Japanese Respiratory Society. The JRS guidelines for the management of ACO 2018. Tokyo: Medical Review; 2017. Japanese
   Google Scholar
• Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128(4):2099–2107. doi:10.1378/chest.128.4.2099
   PubMed Web of Science ®Google Scholar
• McDonald VM, Higgins I, Gibson PG. Managing older peoples with coexistent asthma and chronic obstructive lung disease; diagnostic and therapeutic challenge. Drugs Aging. 2013;30:1–17. doi:10.1007/s40266-012-0042-z
   PubMed Web of Science ®Google Scholar